In 2013, under the national ART guidelines, all patients identified with HIV infection and a CD4 count of <500 cells/mm3 were eligible for ART, up from a CD4 count of <350 cells/mm3 in 2010. This evidence concerns the gene CD4 and HIV infectious disease.